Overview
Cailianshe reported on November 12 that industry data show more than half of 72 life insurers recorded a quarterly loss, and the transmission of investment-side volatility into earnings and solvency has triggered concentrated discussion of long-cycle performance assessment and counter-cyclical mechanisms. It should be stressed that most of the specific adjustments under discussion remain industry proposals and expert views, not enacted regulatory rules.
On the institutional side, what is already established is this: since the Ministry of Finance issued a 2025 notice guiding long-term steady investment of insurance funds and strengthening long-cycle assessment of state-owned commercial insurers, such insurers have been assessed on a combination of five-year, three-year and current-year horizons. The report quotes the general manager of a small life insurer saying joint-venture companies have also been gradually introducing long-cycle assessment by reference to that standard. Several insurance executives proposed incorporating long-term investment returns and long-term dividend ratios into assessment frameworks via regulatory evaluation and industry-association guidance, while optimising tax and assessment policies and lowering transaction costs for long-term equity investment.
A second thread concerns the procyclicality of solvency and accounting rules. Some institutions proposed that, building on an extended transition period for the second phase of the C-ROSS solvency regime and institution-specific treatment, regulators consider introducing counter-cyclical adjustment factors, refining the discount-rate curve, appropriately relaxing the cap on counting future policy surplus as core capital, and optimising equity investment risk factors with differentiated treatment for long holdings and investments aligned with national strategies, so as to dampen procyclical shocks. Other analysis suggested that with IFRS 9 and IFRS 17 fully implemented, counter-cyclical adjustments be introduced into asset impairment and reserve provisioning, and that accounting and solvency liability-valuation curves and interpolation methods be aligned to reduce indicator conflicts under multi-objective management. On technology stocks, which saw sharp fourth-quarter swings, one insurance investment manager said the volatility was somewhat beyond expectations but that insurers would not retrench.
Background & Interpretation
1. Regulatory and Industry Context
Insurance capital, with long-duration liabilities and stable sources, is viewed as one of capital markets’ most representative forms of patient capital, and the 15th Five-Year Plan explicitly calls for strengthening patient capital and improving the policy system supporting mid- and long-term market entry. Implementation lags, however. Full adoption of C-ROSS Phase II has made capital measurement more prudent and risk coverage broader, so rate volatility, equity swings and asset-liability matching pressure jointly raise capital consumption. At the same time, IFRS 9 puts more financial assets at fair value with changes flowing directly through profit or loss, so equity-market swings show up faster and more completely in earnings. Together the two regimes markedly raise the sensitivity of quarterly results to short-term market moves. Meanwhile, reinvestment needs in a low-rate environment coexist with a medium-term trend toward higher equity allocation, creating tension between near-term book-profit pressure and strategic accumulation.
2. Core Drivers and Underlying Mechanism
Procyclicality arises at three stages. First, measurement: as assets measured at fair value through profit or loss take a larger share, unrealised losses hit current earnings directly, and the shorter the assessment window, the more investment decisions are forced to follow market sentiment. Second, capital: the discount-rate curve, the share of future policy surplus counted as core capital, and equity risk factors jointly determine capital consumption; in a downturn, shrinking asset values and rising risk factors can compound, squeezing allocation room. Third, assessment: a framework dominated by time-weighted returns, supplemented by quarterly and annual rankings, poorly reflects the true return of long holdings and mismatches liabilities with durations beyond a decade. Proposals for counter-cyclical factors, convergence of the two curve methodologies, and shifting the evaluation core from time-weighted to capital-weighted returns target exactly these three stages. Refining discount rates and relaxing the future-surplus cap aim to stop short-term market swings being mechanically amplified into capital constraints, while long-cycle assessment and tolerance mechanisms act on decision-makers’ incentives.
3. Market Structure and Industry Chain Impact
For large insurers and insurance asset managers, if assessment and capital rules tilt further toward long horizons, equity allocation, long-term equity investment and infrastructure debt investment plans may gain strategic weight, with portfolios constructed around a high-dividend core balanced across growth and cyclical exposures; the reporting also notes year-end insurer equity positioning has grown more cautious. For small and mid-sized insurers, thinner capital buffers and limited ALM and research resources mean they could benefit relatively more from rule changes, though institution-specific treatment also implies higher differentiated regulatory requirements. For capital markets, the stability of insurer allocation as a ballast bears on the real effectiveness of policies bringing in long-term funds; for listed companies, a rising share of long-term capital supports a better investor base and governance expectations. For accounting, actuarial, risk systems and data providers, coordinating multiple valuation methodologies, counter-cyclical scenario modelling and multi-objective indicator conflicts create demand for system upgrades and advisory work. Again, most of the above remains industry proposal; whether and how rules change depends on formal regulatory issuance.
Implications & Outlook
Near term, fourth-quarter equity swings may keep affecting book profits, with annual assessment pressure coexisting alongside stated intentions not to retrench, making high-dividend holdings and balanced sector allocation the likely transitional choice. Three medium-term variables matter: follow-up details on the C-ROSS Phase II transition and institution-specific treatment; whether counter-cyclical factors, discount-rate curves and equity risk factors enter formal rules; and whether long-cycle assessment extends from large state-owned institutions across the industry, with matching tolerance mechanisms. Long term, if accounting classification, solvency measurement and performance assessment form a consistent long-term incentive, insurer decisions will rest more on liability characteristics, asset fundamentals and long-term value than on quarterly rankings or sentiment — a precondition both for weathering cycles and for patient capital to function. If conflicts between regimes persist, the procyclical amplification of capital constraints and profit swings will be hard to eliminate.
Takeaways for Industry Participants
Insurers should first build an integrated internal view linking asset-liability duration, cost-return matching and capital consumption, ensure accounting classification reflects genuine investment intent, and avoid using classification choices as a profit-smoothing tool; they should also extend look-through long-cycle assessment to investment departments, insurance asset managers and external mandataries, with benchmarks and tolerance bands matched to liability features. Smaller insurers should prioritise capital buffers, research and data capability to leave room for possible differentiated requirements. Systems and data vendors can develop tools for consistency across valuation methodologies and counter-cyclical scenario testing, bounded by formal regulatory rules. For observers and market participants, insurer behaviour should be read across three layers — rules in force, industry proposals and individual statements — without treating debated adjustments as settled policy; operating quality should be judged on underwriting, investment and capital adequacy together, not a single quarter’s profit figure.
This column compiles industry information and shares technical perspectives; it does not constitute investment advice.